Skip to main content

Table 6 Characteristics of 6 locally advanced patients with resection

From: Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status

NoAge
(years)
GenderFactor of unresectabilityAdjuvant
chemotherapy
Adjuvant
radiotherapy
Type of ***
Hepatectomy
Vascular
resection
pLNResidual
tumor
Survival
(status)
1)50’sFBiliary*G (3 cycles)36GyS1,4,5,6,7,8PV1R222.5 m (Dead)
2)80’sMBiliary*GS (2 cycles)S1,5,6,7,81R08.8 m (Dead)
3)60’sMBiliary*GS (2 cycles) +
GC (4 cycles)
36GyS1,2,3,4PV0R149.4 m (Dead)
4)50’sMBiliary*GS (2 cycles)S1,5,6,7,8PV1R047.0 m (Alive)
5)70’sFVascular (HA)**GS (10 cycles)S1,5,6,7,80R049.5 m (Alive)
6)60’sMVascular (HA)**GS (4 cycles)S1,2,3,4HA0R030.4 m
(Alive)
  1. *Biliary factor: biliary margin negative could not be obtained by either side of right or left trisectionectomy
  2. **Vascular factor: Unreconstructible HA and/or PV due to tumor involvement or occlusion
  3. *** Expressed as Couinoud’s hepatic segments resected
  4. G gemcitabine, GS gemcitabine + TS-1, GC gemcitabine + cisplatin, PV portal vein, HA hepatic artery, LN lymph node, R1 microscopic residual tumor resection, R2 macroscopic residual tumor resection or distant metastasis (intrahepatic metastasis)